NDMA

Update on Ranitidine/Zantac

As you may have read, the FDA recently released a warning regarding Ranitidine a medication frequently used for heartburn.  They reported that they found low levels of a carcinogenic impurity called NDMA (N-nitodimetylamine) in some ranitidine medications including the brand name version, Zantac.  Recently, this same impurity was found in other blood pressure medications that were recalled.

Pages

Subscribe to RSS - NDMA

DDAR Blog

5/12/20

Small Intestinal Bacterial Overgrowth

What is SIBO?

Small Intestine Bacterial Overgrowth (SIBO) is a chronic bacterial infection of the small intestine.  The infection is of...

Latest News

5/12/20
Dear Patients   We are waiting for additional direction from the Governor's Office, CDC and Local Regulatory Authorities to reopen our office for elective procedures and non-urgent patient visits. We...